Literature DB >> 24427564

Waldenstrom macroglobulinemia presenting as isolated persistent epistaxis: a very rare presentation.

Vinish Agarwal1, Saurabh Varshney1, S S Bist1, Sanjiv Bhagat1, Sarita Mishra1, Mamta Goyal2, Geeta Negi3, Namita Kabdiwal1.   

Abstract

Nose bleed is the most common rhinological emergency. There are multiple risk factors for the development of epistaxis and it can affect any age group, but it is the elderly population with their associated morbidity who often require more intensive treatment and subsequent admission. Most cases of epistaxis occur in the Little's area, a location readily accessible and treatable by cautery or anterior nasal packing. However, posterior epistaxis often requires more aggressive measures including posterior nasal packing and endoscopic cauterization. After posterior nasal packing, the two most common therapies for intractable epistaxis are transantral ligation of the internal maxillary artery and percutaneous embolization of the distal internal maxillary artery. However, optimal management of intractable posterior epistaxis remains controversial. We hereby report fourth case of Waldenstrom Macroglobulinemia in English literature, which presented as isolated persistent epistaxis and was treated by therapeutic plasmapheresis.

Entities:  

Keywords:  Embolization; Epistaxis; Little’s area; Plasmapheresis; Waldenstrom macroglobulinemia

Year:  2012        PMID: 24427564      PMCID: PMC3649036          DOI: 10.1007/s12070-012-0613-7

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  10 in total

1.  Treatment of Waldenstrom's macroglobulinemia by plasmapheresis.

Authors:  P J SCHWAB; J L FAHEY
Journal:  N Engl J Med       Date:  1960-09-22       Impact factor: 91.245

2.  Waldenström's macroglobulinaemia presenting as isolated epistaxis: a common complaint but a rare cause.

Authors:  Karim Bakri; Ali A Haydar; Jeremy Davis; Jon Wan Der Walt; Majid Kazmi; David J A Goldsmith
Journal:  Int J Clin Pract       Date:  2004-01       Impact factor: 2.503

3.  The frequency of epistaxis in a male population sample.

Authors:  B Petruson; R Rudin
Journal:  Rhinology       Date:  1975-11       Impact factor: 3.681

4.  Idiopathic intractable epistaxis: endovascular therapy.

Authors:  J Vitek
Journal:  Radiology       Date:  1991-10       Impact factor: 11.105

5.  Epistaxis: A retrospective clinical study.

Authors:  Saurabh Varshney; R K Saxena
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2005-04

6.  Therapeutic percutaneous embolization in intractable epistaxis.

Authors:  J Sokoloff; I Wickbom; D McDonald; F Brahme; T C Goergen; L E Goldberger
Journal:  Radiology       Date:  1974-05       Impact factor: 11.105

7.  Waldenström's macroglobulinaemia: a cause of epistaxis in the elderly.

Authors:  I Wright
Journal:  J Laryngol Otol       Date:  1966-02       Impact factor: 1.469

8.  Prognostic factors in Waldenström's macroglobulinemia: a report of 167 cases.

Authors:  T Facon; M Brouillard; A Duhamel; P Morel; M Simon; J P Jouet; F Bauters; P Fenaux
Journal:  J Clin Oncol       Date:  1993-08       Impact factor: 44.544

9.  Plasma exchange in the long-term management of Waldenström's macroglobulinemia.

Authors:  N A Buskard; D A Galton; J M Goldman; E M Kohner; C F Grindle; D L Newman; K W Twinn; R M Lowenthal
Journal:  Can Med Assoc J       Date:  1977-07-23       Impact factor: 8.262

10.  Epistaxis: anatomical and clinical correlates.

Authors:  N Padgham
Journal:  J Laryngol Otol       Date:  1990-04       Impact factor: 1.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.